Vanessa Arce Email

Sr. Controller . Northwest Biotherapeutics

Current Roles

Employees:
20
Revenue:
$1.7M
About
Northwest Biotherapeutics is developing two drug platforms -- DCVax and HuRx -- based on monoclonal antibodies. The company's patented monoclonal antibodies are designed to attach to cancer-causing antigens and kill cancer cells in cancers ranging from prostate and brain cancer to skin and breast cancer.
Northwest Biotherapeutics Address
4800 Montgomery Lane
Bethesda, MD
United States
Northwest Biotherapeutics Email
Northwest Biotherapeutics Phone Numbers
240-497-9024

Past Companies

Northwest BiotherapeuticsSr. Controller
SenecaOne FinanceSr. Controller
Homespire MortgageController

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.